Company name Avinger, Inc.
Stock symbol AVGR
Status Under Investigation

NEW YORK, May 19, 2017 – Bragar Eagel & Squire, P.C. is investigating potential claims against Avinger, Inc. (NASDAQ: GRAM). Our investigation concerns whether Avinger has violated the federal securities laws and/or engaged in other unlawful business practices.

Avinger designs, manufactures, and sells medical devices used to treat patients with peripheral arterial disease. The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.

On January 30, 2015, Avinger held its IPO at $13 per share. On July 12, 2016, the Company announced second quarter revenue results and lowered its 2016 sales guidance from $25 – $30 million to $19 – $23 million, due in part to lower than anticipated sales of the Company’s Pantheris device. Following this news, Avinger shares fell $4.54 per share, or over 39.7%, to close at $6.89 on July 13, 2016.

Avinger shares have continued to decline. On May 17, 2017, shares closed at $0.40, a decline of over 96.9% from the IPO price.

If you purchased or otherwise acquired Avinger securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

First name*

Last name*

City, state, ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?

Call to provide more information: Tel: (212) 308-5858

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.